Curable composition, cured product, color filter, partition, image display device and method for producing cured product
A curable composition with epoxy and carboxyl compounds, along with a thermal base generator, addresses storage stability and solvent resistance issues, enabling effective low-temperature curing for color filters and image display devices.
Patent Information
- Application Number
- JP2023076350
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-02
- Publication Date
- 2024-11-15
AI Technical Summary
Existing curable compositions used in materials like epoxy materials face issues with storage stability and solvent resistance, particularly when using amine compounds as curing agents, which react with epoxy groups over time, leading to decreased stability.
A curable composition comprising a compound with an epoxy group, a compound with a carboxyl group, and a thermal base generator that generates a 4-aminopyridine skeleton upon heating, along with a polymerizable compound and a photopolymerization initiator, to enhance solvent resistance and stability during low-temperature storage.
The composition achieves excellent solvent resistance and stability over time, allowing for effective curing at low temperatures without significant degradation, suitable for producing color filters and image display devices.
Smart Images

Figure 2024160873000001 
Figure 2024160873000002 
Figure 2024160873000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a curable composition, a cured product, a color filter, a partition wall, an image display device, and a method for producing the cured product. [Background technology]
[0002] Thermally polymerizable materials, which are polymerized by heating, and photopolymerizable materials, which are polymerized by irradiation with light, are widely used because the polymerization reaction can be precisely controlled with relatively simple operations, and they occupy an important position, for example, in the fields of electronic materials and printing materials.
[0003] For example, when an epoxy-based material is used as the polymerizable material, an amine compound or the like is used as a curing agent for the epoxy-based material because it allows for low-temperature baking. However, when an amine compound is used as a curing agent for an epoxy material, it may react with the epoxy groups present in the composition over time, resulting in a decrease in storage stability (see, for example, Patent Document 1).
[0004] In view of achieving both storage stability and low-temperature baking in a short time, Patent Document 1 proposes a radiation-sensitive resin composition containing [A] (A1) an alkali-soluble resin obtained by copolymerizing at least one compound selected from the group consisting of unsaturated carboxylic acids and unsaturated carboxylic anhydrides with (A2) an epoxy group-containing unsaturated compound, [B] a polymerizable compound having an ethylenically unsaturated bond, [C] a radiation-sensitive polymerization initiator, and [D] a compound represented by formula (1) (such as an ammonium salt or a phosphonium salt), as well as a cured product and a color filter formed using the same. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2012-048201 A Summary of the Invention [Problem to be solved by the invention]
[0006] In addition to the radiation-sensitive resin compositions described in the above-mentioned patent documents, there is a demand for curable compositions that are excellent in solvent resistance during curing and stability over time during low-temperature storage.
[0007] An object of the present disclosure is to provide a curable composition having excellent solvent resistance and temporal stability during low-temperature storage, a cured product obtained by curing the curable composition, a color filter, a partition wall, and an image display device each including the cured product, and a method for producing the cured product using the curable composition. [Means for solving the problem]
[0008] Specific means for solving the above problems are as follows. <1> (A) a compound having an epoxy group; (B) a compound having a carboxy group; (D) a curing agent, The curable composition, wherein the (D) curing agent is a thermal base generator containing a compound represented by the following general formula (a) which generates a base having a 4-aminopyridine skeleton upon heating:
[0009] [ka]
[0010] In the general formula (a), R1 is a hydrogen atom or a monovalent substituent, and R 11 ~R 14 are each independently a hydrogen atom or a monovalent substituent, and R2 is a monovalent substituent in which the atom bonded to the carbonyl carbon in general formula (a) is a carbon atom, an oxygen atom, or a sulfur atom. <2> (E) Further containing a polymerizable compound <1> The curable composition according to claim 1. <3> (F) Further containing a photopolymerization initiator <1> or <2> The curable composition according to claim 1. <4> (G) Further containing a colorant <1> ~ <3> 13. The curable composition according to claim 12, <5> The (E) polymerizable compound contains a (meth)acrylate compound. <2> The curable composition according to claim 1. <6> In the general formula (a), R1 is a monovalent substituent, and the monovalent substituent is an alkyl group. <1> ~ <5> 13. The curable composition according to claim 12, <7> In the general formula (a), R2 is an optionally substituted phenyl group, an optionally substituted alkoxy group, an optionally substituted alkyl group, or an optionally substituted thioalkyl group. <1> ~ <6> 13. The curable composition according to claim 12, <8> The general formula (a) satisfies the following general formula (a-1): <1> ~ <7> 13. The curable composition according to claim 12,
[0011] [ka]
[0012] In the general formula (a-1), R1 is a hydrogen atom or a monovalent substituent, and R 11 ~R 14 and R 21 ~R 24 are each independently a hydrogen atom or a monovalent substituent, and R3 is an electron-donating group or an electron-withdrawing group. <9> In the general formula (a-1), R3 is an alkoxy group or a nitro group. <8> The curable composition according to claim 1. <10> <1> ~ <9> 2. A cured product obtained by curing the curable composition according to claim 1. <11> <10> A color filter comprising the cured product according to claim 1. <12> <10> A partition wall comprising the cured product according to claim 1. <13> <10> An image display device comprising the cured product according to claim 1. <14> <3> A method for producing a cured product, comprising at least the following steps (1) to (4), using the curable composition according to the above item (1). Step (1): Forming a coating film of the curable composition on a substrate Step (2): A step of exposing at least a part of the coating film formed in step (1) to light. Step (3): A step of developing the coating film exposed in step (2) Step (4): Heating the coating film developed in step (3) <15> The heating temperature in the step (4) is 180° C. or less. <14> A method for producing the cured product according to claim 1. Effect of the Invention
[0013] According to one embodiment of the present invention, it is possible to provide a curable composition having excellent solvent resistance and temporal stability during low-temperature storage, a cured product obtained by curing the curable composition, a color filter, a partition wall, and an image display device each including the cured product, and a method for producing the cured product using the curable composition. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] In the present disclosure, a numerical range expressed using "to" means a range that includes the numerical values before and after "to" as the lower and upper limits. In the numerical ranges described in the present disclosure in stages, the upper or lower limit value described in one numerical range may be replaced with the upper or lower limit value of another numerical range described in stages. In addition, in the numerical ranges described in the present disclosure, the upper or lower limit value of the numerical range may be replaced with a value shown in the examples. In the present disclosure, each component may contain multiple types of corresponding substances. When multiple substances corresponding to each component are present in the composition, the content of each component means the total content of the multiple substances present in the composition, unless otherwise specified. In the present disclosure, "(meth)acrylic" means "either one or both of acrylic and methacrylic." In the present disclosure, the term "total solids" refers to all components in the curable composition other than the solvent. Even if a component other than the solvent is liquid at room temperature, the component is not included in the solvent but is included in the total solids. In the present disclosure, the partition wall means a bank, a wall, or a wall. The partition wall is used to partition a functional layer (organic layer) in, for example, an active-drive organic electroluminescent device, and is used to form pixels, etc., each of which is made up of the functional layer and the partition wall, by applying a material for forming the functional layer to the partitioned region (pixel region) by vapor deposition or inkjet or the like, and then drying the material. In this disclosure, unless otherwise specified, the weight average molecular weight means the weight average molecular weight (Mw) calculated in terms of polystyrene by GPC (gel permeation chromatography).
[0015] [Curable composition] The curable composition of the present disclosure comprises (A) a compound having an epoxy group, (B) a compound having a carboxy group, and (D) a curing agent, wherein the (D) curing agent is a thermal base generator represented by the following general formula (a) and comprises a compound that generates a base having a 4-aminopyridine skeleton upon heating.
[0016] [ka]
[0017] In the general formula (a), R1 is a hydrogen atom or a monovalent substituent, and R 11 ~R 14 are each independently a hydrogen atom or a monovalent substituent, and R2 is a monovalent substituent in which the atom bonded to the carbonyl carbon in general formula (a) is a carbon atom, an oxygen atom, or a sulfur atom.
[0018] The curable composition of the present disclosure has excellent solvent resistance and stability over time during storage at low temperatures. The reason for this is presumed to be as follows. Note that the present disclosure is not limited to the following presumption. The curable composition of the present disclosure contains a compound having a carboxy group (B), and the carboxylate derived from the compound causes a nucleophilic acyl substitution reaction with the compound contained in the curing agent (D), which generates a base when heated. This generates a base having a 4-aminopyridine skeleton that is highly active against epoxy groups. The action of the generated base causes a crosslinking reaction based on the epoxy ring-opening of the compound having an epoxy group (A). The crosslinking reaction proceeds with good reactivity due to the generation of 4-methylaminopyridine that is highly active against epoxy groups, and the obtained cured product exhibits good solvent resistance. Furthermore, when the curable composition of the present disclosure is stored at a low temperature (for example, at 5° C.), the generation of a base from the curing agent (D) is suppressed, and the curing agent (D) has low activity against epoxy groups. Therefore, the curable composition has excellent stability over time when stored at a low temperature.
[0019] ((A) Compound having an epoxy group) The curable composition of the present disclosure contains (A) a compound having an epoxy group (hereinafter also referred to as "component (A)").
[0020] The component (A) can be appropriately selected from known epoxy resins and the like. The epoxy resin may be a compound obtained by reacting a phenolic compound with epihalohydrin. The phenolic compound is preferably a compound having a divalent or trivalent or higher phenolic hydroxyl group, and may be a monomer or a polymer. Examples of epoxy resins include bisphenol A type epoxy resins, bisphenol F type epoxy resins, bisphenol S type epoxy resins, bisphenol AD type epoxy resins, hydrogenated bisphenol A type epoxy resins, biphenyl type epoxy resins, phenol novolac type epoxy resins, cresol novolac type epoxy resins, biphenyl novolac type epoxy resins, trisphenol type epoxy resins, naphthalene type epoxy resins, hydroquinone type epoxy resins, tertiary butyl catechol type epoxy resins, dicyclopentadiene type epoxy resins, biphenyl ether type epoxy resins, phosphorus-containing epoxy resins, glycidylamine type epoxy resins, triglycidyl isocyanurate type epoxy resins, polymerized epoxy resins of phenol and dicyclopentane, dihydroxylfluorene type epoxy resins, dihydroxylalkyleneoxylfluorene type epoxy resins, diglycidyl ethers of 9,9-bis(4'-hydroxyphenyl)fluorene, and diglycidyl ethers of 1,1-bis(4'-hydroxyphenyl)adamantane. The component (A) may use one type alone, or two or more types in combination.
[0021] The content of the component (A) may be 5% by mass to 70% by mass, 10% by mass to 75% by mass, 20% by mass to 70% by mass, 25% by mass to 65% by mass, or 30% by mass to 60% by mass, relative to the total solid content of the curable composition.
[0022] ((B) Compound having a carboxy group) The curable composition of the present disclosure contains (B) a compound having a carboxy group (hereinafter also referred to as "component (B)").
[0023] The component (B) can be appropriately selected from known compounds having a carboxy group, etc. The component (B) may be an alkali-soluble resin, a monomer having a carboxy group, etc.
[0024] The (B) component may be a polymer containing a structural unit derived from (meth)acrylic acid, or may be a copolymer containing a structural unit derived from (meth)acrylic acid and a structural unit derived from a (meth)acrylate compound. The component (B) may contain one type of structural unit derived from a (meth)acrylate compound, or may contain two or more types. The component (B) may be an unsaturated monocarboxylic acid such as (meth)acrylic acid, an unsaturated dicarboxylic acid such as maleic acid, a carboxylic acid having one ethylenically unsaturated bond, a saturated carboxylic acid, etc. The component (B) may be an anhydride (for example, an anhydride of an unsaturated dicarboxylic acid, an anhydride of a saturated dicarboxylic acid). The component (B) preferably contains a structural unit represented by the following general formula (I): The structural unit represented by general formula (I) corresponds to a structural unit derived from (meth)acrylic acid.
[0025] [ka]
[0026] In general formula (I), R 3 is a hydrogen atom or a methyl group.
[0027] The component (B) may contain a structural unit represented by the following general formula (II), or may contain a structural unit represented by the above general formula (I) and a structural unit represented by the following general formula (II). The structural unit represented by general formula (II) corresponds to a structural unit derived from a (meth)acrylate compound.
[0028] [ka]
[0029] In general formula (II), R 3 is a hydrogen atom or a methyl group, R 4 is a monovalent organic group.
[0030] R 4Examples of the monovalent organic group in include an alkyl group which may have a substituent, an aromatic ring group which may have a substituent, and an alkenyl group which may have a substituent.
[0031] R 4 The alkyl group in the formula (I) may be a straight-chain, branched-chain or cyclic alkyl group. Specific examples of the alkyl group include a methyl group, an ethyl group, a propyl group, a 2-ethylhexyl group, a cyclohexyl group, a dicyclopentanyl group, and a dodecanyl group.
[0032] Examples of the substituent that the alkyl group may have include a methoxy group, an ethoxy group, a chloro group, a bromo group, a fluoro group, a hydroxy group, an amino group, an oligoethylene glycol group, a phenyl group, a carboxyl group, an acryloyl group, and a methacryloyl group. From the viewpoint of developability, a hydroxy group and an oligoethylene glycol group are preferred, and from the viewpoints of curability and solvent resistance, an acryloyl group and a methacryloyl group are preferred.
[0033] R 4 Examples of the aromatic ring group in the formula (I) include a monovalent aromatic hydrocarbon ring group and a monovalent aromatic heterocyclic group. The aromatic hydrocarbon ring in the aromatic hydrocarbon ring group may be a single ring or a condensed ring, and examples thereof include a benzene ring, a naphthalene ring, an anthracene ring, a phenanthrene ring, a perylene ring, a tetracene ring, a pyrene ring, a benzpyrene ring, a chrysene ring, a triphenylene ring, an acenaphthene ring, a fluoranthene ring, and a fluorene ring. The aromatic heterocycle in the aromatic heterocycle group may be a single ring or a condensed ring, and examples thereof include a furan ring, a benzofuran ring, a thiophene ring, a benzothiophene ring, a pyrrole ring, a pyrazole ring, an imidazole ring, an oxadiazole ring, an indole ring, a carbazole ring, a pyrroloimidazole ring, a pyrrolopyrazole ring, a pyrrolopyrrole ring, a thienopyrrole ring, a thienothiophene ring, a furopyrrole ring, a furofuran ring, a thienofuran ring, a benzisoxazole ring, a benzisothiazole ring, a benzimidazole ring, a pyridine ring, a pyrazine ring, a pyridazine ring, a pyrimidine ring, a triazine ring, a quinoline ring, an isoquinoline ring, a cinnoline ring, a quinoxaline ring, a phenanthridine ring, a perimidine ring, a quinazoline ring, a quinazolinone ring, and an azulene ring.
[0034] Examples of the substituent that the aromatic ring group may have include a methyl group, an ethyl group, a propyl group, a methoxy group, an ethoxy group, a chloro group, a bromo group, a fluoro group, a hydroxy group, an amino group, an oligoethylene glycol group, a phenyl group, and a carboxyl group. From the viewpoint of developability, a hydroxy group and an oligoethylene glycol group are preferred.
[0035] R 4 The alkenyl group in may be a linear, branched or cyclic alkenyl group having 2 or more carbon atoms, and preferably 22 or less, more preferably 20 or less, even more preferably 18 or less, even more preferably 16 or less, and particularly preferably 14 or less.
[0036] Examples of the substituent that the alkenyl group may have include a methoxy group, an ethoxy group, a chloro group, a bromo group, a fluoro group, a hydroxy group, an amino group, an oligoethylene glycol group, a phenyl group, and a carboxyl group. From the viewpoint of developability, a hydroxy group and an oligoethylene glycol group are preferred.
[0037] The component (B) contains a structural unit derived from (meth)acrylic acid as the structural unit represented by the general formula (I), and contains the structural unit represented by the general formula (II) R 4A structural unit derived from a (meth)acrylate compound in which R is a linear or branched alkyl group (e.g., a 2-ethylhexyl group), and 4 It is preferable that the compound contains a structural unit derived from a (meth)acrylate compound in which R is a cyclic alkyl group (for example, a dicyclopentanyl group).
[0038] The proportion of structural units derived from (meth)acrylic acid in component (B) (preferably structural units represented by general formula (I)) is preferably 5 mol% or more, more preferably 10 mol% or more, and even more preferably 20 mol% or more, and is preferably 80 mol% or less, more preferably 70 mol% or less, and even more preferably 60 mol% or less, based on the total number of moles of all structural units. By making it 5 mol% or more, solvent resistance tends to improve, and by making it 80 mol% or less, adhesion tends to improve.
[0039] (B) R in component 4 The ratio of structural units derived from a (meth)acrylate compound in which is a linear or branched alkyl group is preferably 1 mol% or more, more preferably 2 mol% or more, and even more preferably 5 mol% or more, and is preferably 40 mol% or less, more preferably 30 mol% or less, even more preferably 20 mol% or less, and particularly preferably 18 mol% or less, based on the total number of moles of all structural units. By making it 1 mol% or more, solvent resistance and adhesion tend to be improved, and by making it 40 mol% or less, developability tends to be improved.
[0040] (B) R in component 4 The ratio of structural units derived from a (meth)acrylate compound in which is a cyclic alkyl group is preferably 1 mol% or more, more preferably 2 mol% or more, and even more preferably 5 mol% or more, and is preferably 40 mol% or less, more preferably 30 mol% or less, even more preferably 20 mol% or less, and particularly preferably 18 mol% or less, based on the total number of moles of all structural units. By making it 1 mol% or more, solvent resistance and adhesion tend to be improved, and by making it 40 mol% or less, developability tends to be improved.
[0041] The component (B) may contain a carboxylic acid monomer, such as an unsaturated monocarboxylic acid, such as (meth)acrylic acid, an unsaturated dicarboxylic acid, such as maleic acid, or a carboxylic acid having one ethylenically unsaturated bond. Examples of the unsaturated monocarboxylic acid include acrylic acid, methacrylic acid, crotonic acid, and α-(hydroxymethyl)acrylic acid. The unsaturated dicarboxylic acid includes unsaturated dicarboxylic acids such as maleic acid, fumaric acid, citraconic acid, mesaconic acid, itaconic acid, and the like; and anhydrides of the above-mentioned unsaturated dicarboxylic acids. Examples of carboxylic acids having one ethylenically unsaturated bond include unsaturated mono[(meth)acryloyloxyalkyl] esters of divalent or higher polyvalent carboxylic acids such as mono[2-(meth)acryloyloxyethyl] succinate and mono[2-(meth)acryloyloxyethyl] phthalate.
[0042] As other components (B), for example, the epoxy (meth)acrylate resins described in WO 2018 / 101314 can also be used.
[0043] The content of the component (B) may be 20% by mass to 70% by mass, 25% by mass to 65% by mass, or 30% by mass to 60% by mass, based on the total solid content of the curable composition.
[0044] The curable composition may contain separate compounds as (A) a compound having an epoxy group (component (A)) and (B) a compound having a carboxy group (component (B)), or may contain (C) a compound having an epoxy group and a carboxy group (hereinafter also referred to as "component (C)") as component (A) and component (B).
[0045] Examples of the component (C) include compounds that contain a structural unit having a carboxy group and a structural unit that contains a monovalent substituent having an epoxy group (for example, a glycidyl ether group). Examples of the structural unit having a carboxy group include the structural unit derived from the above-mentioned (meth)acrylic acid. Examples of structural units containing a monovalent substituent having an epoxy group (for example, a glycidyl ether group) include structural units derived from a compound having an aliphatic epoxy group, such as a structural unit represented by the following general formula (III). [ka]
[0046] In general formula (III), R 3 is a hydrogen atom or a methyl group, R 5 is a monovalent substituent having an epoxy group (for example, a glycidyl ether group). Examples of the monovalent substituent having an epoxy group include an alkyl group having an epoxy group, an aromatic ring group having an epoxy group, and an alkenyl group having an epoxy group. Specific examples of the compound having an aliphatic epoxy group include glycidyl (meth)acrylate, β-methylglycidyl (meth)acrylate, β-ethylglycidyl (meth)acrylate, glycidyl vinyl ether, and the compound represented by the following formula described in JP-A-7-248625. In the following formula, R 11 ~R 13 each independently represents a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, and m is an integer of 1 to 5.
[0047] [ka]
[0048] Examples of the compound represented by the above formula include o-vinylbenzyl glycidyl ether, m-vinylbenzyl glycidyl ether, p-vinylbenzyl glycidyl ether, α-methyl-o-vinylbenzyl glycidyl ether, α-methyl-m-vinylbenzyl glycidyl ether, α-methyl-p-vinylbenzyl glycidyl ether, 2,3-diglycidyloxymethylstyrene, 2,4-diglycidyloxymethylstyrene, 2,5-diglycidyloxymethylstyrene, 2,6-diglycidyloxymethylstyrene, 2,3,4-triglycidyloxymethylstyrene, 2,3,5-triglycidyloxymethylstyrene, 2,3,6-triglycidyloxymethylstyrene, 3,4,5-triglycidyloxymethylstyrene, and 2,4,6-triglycidyloxymethylstyrene.
[0049] Examples of the structural unit containing a monovalent substituent having an epoxy group include the structural units described in JP 2018-004841 A, for example, a structural unit represented by general formula (2).
[0050] [ka]
[0051] In general formula (2), R 1 R is a hydrogen atom or a methyl group. 2 X is an oxiranyl group, a 3,4-epoxycyclohexyl group, a group represented by the following formula (3-1), or a group represented by the following formula (3-2). 1 represents a single bond, a methylene group, or an alkylene group having 2 to 12 carbon atoms.
[0052] [ka]
[0053] In formulas (3-1) and (3-2), * represents X 1 The binding site is shown.
[0054] The component (C) may contain a structural unit represented by the above general formula (III). The component (C) may further contain at least one of a structural unit represented by the above general formula (I) and a structural unit represented by the above general formula (II), or may further contain both a structural unit represented by the above general formula (I) and a structural unit represented by the following general formula (II). The component (C) is a structural unit represented by the general formula (II), R 4 A structural unit derived from a (meth)acrylate compound in which R is a linear or branched alkyl group (e.g., a 2-ethylhexyl group), and 4 may contain a structural unit derived from a (meth)acrylate compound in which the alkyl group is a cyclic alkyl group (for example, a dicyclopentanyl group).
[0055] When component (C) contains a structural unit represented by general formula (I), the preferred proportion of the structural unit represented by general formula (I) in component (C) is the same as the preferred proportion of the structural unit represented by general formula (I) in component (B) described above. (C) Component is R 4 In the case where the (C) component contains a structural unit derived from a (meth)acrylate compound in which R is a linear or branched alkyl group, 4 When the copolymer contains a structural unit derived from a (meth)acrylate compound in which R is a cyclic alkyl group, the preferred proportions of the respective structural units are the same as the preferred proportions of the respective structural units in the component (B) described above.
[0056] When the (C) component contains a structural unit represented by general formula (III), the ratio of the structural unit represented by general formula (III) in the (C) component is preferably 5 mol% or more, more preferably 10 mol% or more, even more preferably 20 mol% or more, and preferably 80 mol% or less, more preferably 70 mol% or less, and even more preferably 60 mol% or less, based on the total number of moles of all structural units. By making it 5 mol% or more and 80 mol% or less, the solvent resistance and the strength of the cured product tend to be improved.
[0057] The curable composition comprises It may contain a component (A) that does not contain a carboxy group and a component (B) that does not contain an epoxy group, The composition may contain only the component (C) having an epoxy group and a carboxy group, It may contain at least one of component (A) which does not contain a carboxy group and component (B) which does not contain an epoxy group, and component (C) which has an epoxy group and a carboxy group.
[0058] The content of the component (C) may be 20% by mass to 70% by mass, 25% by mass to 65% by mass, or 30% by mass to 60% by mass, based on the total solid content of the curable composition.
[0059] In the curable composition, the total content of the component having an epoxy group and the component having a carboxy group may be 20% by mass to 70% by mass, 25% by mass to 65% by mass, or 30% by mass to 60% by mass, relative to the total solid content of the curable composition.
[0060] ((D) Hardener) The curable composition of the present disclosure contains a curing agent (D). The curing agent (D) is a thermal base generator that contains a compound represented by the following general formula (a) and that generates a base having a 4-aminopyridine skeleton upon heating (for example, heating at 180° C.).
[0061] [ka]
[0062] In the general formula (a), R1 is a hydrogen atom or a monovalent substituent, and R 11 ~R 14 are each independently a hydrogen atom or a monovalent substituent, and R2 is a monovalent substituent in which the atom bonded to the carbonyl carbon in general formula (a) is a carbon atom, an oxygen atom, or a sulfur atom.
[0063] By heating the curable composition containing a thermal base generator, a base is generated from the thermal base generator, and the functional groups contained in the (A) component and the like in the curable composition react due to the action of the generated base. Therefore, by heating the above-mentioned curable composition to generate a base, the (A) component and the like react to obtain a cured product.
[0064] The thermal base generator is a compound represented by general formula (a) and includes a compound in which a substituent containing an amide group is bonded to the 4-position of pyridine. By heating a curable composition containing the thermal base generator, a base having a 4-aminopyridine skeleton is generated from the compound contained in the thermal base generator. The base having a 4-aminopyridine skeleton is a compound represented by the following general formula (b).
[0065] [ka]
[0066] R and R in general formula (b) 11 ~R 14 R and R in general formula (a) 11 ~R 14 is the same as:
[0067] In addition, the compound represented by the general formula (a) is a non-ionic thermal base generator, and unlike conventional ionic thermal base generators, it has relatively high stability and solubility during storage, and the curable composition using this has high stability. Furthermore, the base generated from the thermal base generator containing the compound represented by the general formula (a) is a base in which a hydrogen atom is bonded to a nitrogen atom having a pyridine skeleton. Therefore, for example, the reactivity of the (A) component when heated is good, and for example, the reaction of the (A) component can be advanced at a relatively low temperature. Furthermore, the compound represented by the general formula (a) contained in the thermal base generator does not cause a decarboxylation reaction by heating. This makes it possible to suppress the generation of bubbles due to the generation of carbon dioxide, the decrease in strength of the cured product, and the like.
[0068] In the compound represented by the general formula (a), when the atom bonded to the carbonyl carbon is a monovalent substituent that is a nitrogen atom, the dispersibility in the curable composition is likely to deteriorate due to hydrogen bonds between the hydrogen atom bonded to the nitrogen atom and the carbonyl carbon. Therefore, in order to improve the dispersibility, an additional solvent is required, and when the cured product is produced, the solvent is likely to not volatilize partially, which leads to poor curing. On the other hand, in the compound represented by the general formula (a), when the atom bonded to the carbonyl carbon is a monovalent substituent that is a carbon atom, an oxygen atom, or a sulfur atom, the generation of the hydrogen bonds as described above is suppressed, so that the dispersibility in the curable composition is good, and additional solvent is not required or the amount of the solvent can be reduced. As a result, poor curing caused by the solvent when producing the cured product can be suppressed.
[0069] In general formula (a), R1 is a hydrogen atom or a monovalent substituent. From the viewpoints of storage stability when made into a curable composition and dispersibility in the curable composition, R1 is preferably a monovalent substituent, and more preferably an alkyl group. The alkyl group in R1 preferably has 1 to 10 carbon atoms, and examples thereof include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a neopentyl group, a tert-pentyl group, a 1-methylbutyl group, an n-hexyl group, a 2-methylpentyl group, a 3-methylpentyl group, a 2,2-dimethylbutyl group, a 2,3-dimethylbutyl group, an n-heptyl group, a 2-methylhexyl group, a 3-methylhexyl group, a 2,2-dimethylpentyl group, a 2,3-dimethylpentyl group, a 2,4-dimethylpentyl group, a 3,3-dimethylpentyl group, a 3-ethylpentyl group, a 2,2,3-trimethylbutyl group, an n-octyl group, an isooctyl group, a 2-ethylhexyl group, a nonyl group, and a decyl group. Among these, a methyl group is preferable.
[0070] In general formula (a), R 11 ~R 14 R is each independently a hydrogen atom or a monovalent substituent. 11 ~R 14Examples of the monovalent substituent in include an alkyl group, an alkoxy group, an aryloxy group, a dialkylamino group, a diarylamino group, an alkylarylamino group, an alkylcarbonyl group, an arylcarbonyl group, an alkyloxycarbonyl group, an aryloxycarbonyl group, an alkylcarbonyloxy group, an arylcarbonyloxy group, an alkylthio group, an arylthio group, a cyano group (-CN), a halogen atom, a nitro group, a haloalkyl group (halogenated alkyl group), a hydroxyl group (-OH), a mercapto group (-SH), an amino group, an aromatic hydrocarbon group, and an aromatic heterocyclic group. R 11 ~R 14 At least two of these may be bonded to each other to form a ring structure.
[0071] In general formula (a), R 11 ~R 14 R is preferably a hydrogen atom or an alkyl group, and more preferably a hydrogen atom. 11 ~R 14 Examples of the alkyl group in are the same as the alkyl groups in R1 described above.
[0072] R 11 ~R 14 Examples of the alkoxy group in the above formula include a monovalent group in which the alkyl group is bonded to an oxygen atom, such as a methoxy group, ethoxy group, n-propoxy group, isopropoxy group, cyclopropoxy group, and n-butoxy group.
[0073] R 11 ~R 14In the aryloxy group in the above, the aryl group bonded to the oxygen atom may be either monocyclic or polycyclic, and preferably has 6 to 10 carbon atoms. Examples of such aryl groups include phenyl, 1-naphthyl, 2-naphthyl, o-tolyl, m-tolyl, p-tolyl, and xylyl (dimethylphenyl) groups, and also include aryl groups in which one or more hydrogen atoms are further substituted with these aryl groups, the above alkyl groups, etc. The aryl groups having these substituents preferably have 6 to 10 carbon atoms including the substituent.
[0074] R 11 ~R 14 In the above, examples of the dialkylamino group include a monovalent group in which two hydrogen atoms of an amino group (-NH2) are substituted with the above alkyl groups, such as a dimethylamino group and a methylethylamino group. In the above dialkylamino group, the two alkyl groups bonded to the nitrogen atom may be the same or different. R 11 ~R 14 Examples of the diarylamino group in the above formula include a monovalent group in which two hydrogen atoms of an amino group are substituted with the above-mentioned aryl group, such as a diphenylamino group or a phenyl-1-naphthylamino group. In the above-mentioned diarylamino group, the two aryl groups bonded to the nitrogen atom may be the same or different. R 11 ~R 14 Examples of the alkylarylamino group in the above formula (I) include monovalent groups in which one of the two hydrogen atoms of an amino group is substituted with the above alkyl group and one of the two hydrogen atoms is substituted with the above aryl group, such as a methylphenylamino group.
[0075] R 11 ~R 14 Examples of the alkylcarbonyl group in the above formula include a monovalent group in which the alkyl group is bonded to a carbonyl group (-C(=O)-), such as a methylcarbonyl group (acetyl group). R 11 ~R 14Examples of the arylcarbonyl group in the above formula include a monovalent group in which the above aryl group is bonded to a carbonyl group, such as a phenylcarbonyl group (benzoyl group).
[0076] R 11 ~R 14 Examples of the alkyloxycarbonyl group in the above formula include a monovalent group formed by bonding an alkoxy group to a carbonyl group, such as a methyloxycarbonyl group (methoxycarbonyl group). R 11 ~R 14 Examples of the aryloxycarbonyl group in the above formula include a monovalent group in which the above aryloxy group is bonded to a carbonyl group, such as a phenyloxycarbonyl group (phenoxycarbonyl group).
[0077] R 11 ~R 14 Examples of the alkylcarbonyloxy group in the above formula include a monovalent group in which the alkyl group is bonded to the carbon atom of a carbonyloxy group (-C(=O)-O-), such as a methylcarbonyloxy group. R 11 ~R 14 Examples of the arylcarbonyloxy group in the above formula include a monovalent group in which the aryl group is bonded to a carbonyloxy group, such as a phenylcarbonyloxy group.
[0078] R 11 ~R 14 Examples of the alkylthio group in the above formula include a monovalent group in which the alkyl group is bonded to a sulfur atom, such as a methylthio group, an ethylthio group, an n-propylthio group, an isopropylthio group, and a cyclopropylthio group. R 11 ~R 14 Examples of the arylthio group in the above formula include a monovalent group in which the above aryl group is bonded to a sulfur atom, such as a phenylthio group, a 1-naphthylthio group, and a 2-naphthylthio group.
[0079] R 11 ~R 14Examples of the halogen atom in include a fluorine atom (-F), a chlorine atom (-Cl), a bromine atom (-Br), and an iodine atom (-I).
[0080] R 11 ~R 14 Examples of the haloalkyl group in the above formula include groups in which one or more hydrogen atoms of the above alkyl group are substituted with halogen atoms. Examples of the halogen atom in the haloalkyl group include those exemplified above as the halogen atom which is a substituent. The number of halogen atoms in the haloalkyl group is not particularly limited, and may be 1 or 2 or more. When the number of halogen atoms in the haloalkyl group is 2 or more, these multiple halogen atoms may be all the same, all different, or only some of them may be the same. The haloalkyl group may be a perhaloalkyl group in which all hydrogen atoms in the alkyl group are replaced with halogen atoms. The haloalkyl group is not particularly limited, and examples thereof include a chloromethyl group, a dichloromethyl group, a trichloromethyl group, and a trifluoromethyl group.
[0081] R 11 ~R 14 Examples of the aromatic hydrocarbon group in include a phenyl group, a naphthyl group, and an anthryl group. One or more hydrogen atoms of these aromatic hydrocarbon groups may be substituted with a substituent such as the above-mentioned aromatic hydrocarbon groups or an alkyl group. The aromatic hydrocarbon group having the above-mentioned substituent preferably has 6 to 20 carbon atoms including the substituent.
[0082] R 11 ~R 14The aromatic heterocyclic group in the above-mentioned formula (1) includes a group obtained by removing one hydrogen atom bonded to a carbon atom or heteroatom constituting the ring skeleton from an aromatic heterocyclic compound. Examples of the aromatic heterocyclic compound include a compound having one or more sulfur atoms as an atom constituting the aromatic heterocyclic skeleton (sulfur-containing aromatic heterocyclic compound), a compound having one or more nitrogen atoms as an atom constituting the aromatic heterocyclic skeleton (nitrogen-containing aromatic heterocyclic compound), a compound having one or more oxygen atoms as an atom constituting the aromatic heterocyclic skeleton (oxygen-containing aromatic heterocyclic compound), and a compound having two different heteroatoms selected from a sulfur atom, a nitrogen atom, and an oxygen atom as atoms constituting the aromatic heterocyclic skeleton.
[0083] Examples of the sulfur-containing aromatic heterocyclic compound include thiophene and benzothiophene.
[0084] Examples of the nitrogen-containing aromatic heterocyclic compound include pyrrole, imidazole, pyrazole, pyridine, pyrazine, pyrimidine, pyridazine, triazine, indole, isoindole, benzimidazole, purine, indazole, quinoline, isoquinoline, quinoxaline, quinazoline, and cinnoline.
[0085] Examples of the oxygen-containing aromatic heterocyclic compound include furan, benzofuran (1-benzofuran), and isobenzofuran (2-benzofuran).
[0086] Examples of the compound having the above-mentioned two different heteroatoms as atoms constituting an aromatic heterocyclic skeleton include oxazole, isoxazole, thiazole, benzoxazole, benzisoxazole, and benzothiazole.
[0087] In general formula (a), R2 is a monovalent substituent in which the atom bonded to the carbonyl carbon in general formula (a) is a carbon atom, an oxygen atom, or a sulfur atom.
[0088] When R2 is a monovalent substituent in which the atom bonded to the carbonyl carbon in general formula (a) is an oxygen atom, R2 is preferably not a structure containing an o-nitrobenzyloxy structure or a fluorenylmethyloxy structure.
[0089] R2 is preferably a phenyl group which may have a substituent, an alkoxy group which may have a substituent, an alkyl group which may have a substituent, or a thioalkyl group which may have a substituent. The alkoxy group which may have a substituent is preferably a linear alkoxy group, the alkyl group which may have a substituent is preferably a linear alkyl group, and the thioalkyl group which may have a substituent is preferably a linear thioalkyl group. The number of carbon atoms of these alkoxy groups, alkyl groups, and thioalkyl groups may be independently 2 to 10, 2 to 6, or 2 to 4. For example, the alkoxy group may be an ethoxy group, an n-propoxy group, an isopropoxy group, an n-butoxy group, or the like, the alkyl group may be an ethyl group, an n-propyl group, an n-butyl group, or the like, and the thioalkyl group may be an ethylthio group, an n-propylthio group, an n-butylthio group, or the like.
[0090] In the present disclosure, examples of substituents that the various functional groups may have include an alkyl group, an alkoxy group, an aryloxy group, a dialkylamino group, a diarylamino group, an alkylarylamino group, an alkylcarbonyl group, an arylcarbonyl group, an alkyloxycarbonyl group, an aryloxycarbonyl group, an alkylcarbonyloxy group, an arylcarbonyloxy group, an alkylthio group, an arylthio group, a cyano group (-CN), a halogen atom, a nitro group, a haloalkyl group (halogenated alkyl group), a hydroxyl group (-OH), a mercapto group (-SH), an amino group, an aromatic hydrocarbon group, and an aromatic heterocyclic group.
[0091] In the optionally substituted phenyl group, optionally substituted alkoxy group, optionally substituted alkyl group, and optionally substituted thioalkyl group for R2, the number of substituents varies depending on the number of substitutable hydrogen atoms, and may be, for example, 0 to 5, 0 to 3, or 0, 1, or 2. When the number of the substituents is two or more, these substituents may all be the same, all be different, or only some of them may be the same.
[0092] R2 may be a phenyl group which may have a substituent, and in this case, general formula (a) preferably satisfies the following general formula (a-1).
[0093] [ka]
[0094] In the general formula (a-1), R1 is a hydrogen atom or a monovalent substituent, and R 11 ~R 14 and R 21 ~R 24 are each independently a hydrogen atom or a monovalent substituent, and R3 is an electron-donating group or an electron-withdrawing group. R and R in general formula (a-1) 11 ~R 14 R and R in general formula (a) 11 ~R 14 is the same as:
[0095] In general formula (a-1), R 21 ~R 24 R is each independently a hydrogen atom or a monovalent substituent. 21 ~R 24Examples of the monovalent substituent in include an alkyl group, an alkoxy group, an aryloxy group, a dialkylamino group, a diarylamino group, an alkylarylamino group, an alkylcarbonyl group, an arylcarbonyl group, an alkyloxycarbonyl group, an aryloxycarbonyl group, an alkylcarbonyloxy group, an arylcarbonyloxy group, an alkylthio group, an arylthio group, a cyano group (-CN), a halogen atom, a nitro group, a haloalkyl group (halogenated alkyl group), a hydroxyl group (-OH), a mercapto group (-SH), an amino group, an aromatic hydrocarbon group, and an aromatic heterocyclic group. R 21 ~R 24 At least two of these may be bonded to each other to form a ring structure.
[0096] In general formula (a-1), R 21 ~R 24 are preferably each independently a hydrogen atom or an alkyl group, and more preferably a hydrogen atom. R 21 ~R 24 Examples of monovalent substituents in the general formula (a) include R 11 ~R 14 The examples of the monovalent substituent are the same as those in the above.
[0097] In general formula (a-1), R3 represents an electron-donating group or an electron-withdrawing group.
[0098] Examples of the electron-donating group include an alkyl group, an alkoxy group, an aryloxy group, a dialkylamino group, a diarylamino group, an alkylarylamino group, an alkylthio group, an arylthio group, -NHCOR (R is a hydrocarbon group which may have a substituent), and -OCOR (R is a hydrocarbon group which may have a substituent). Among these, the electron donating group is preferably an alkoxy group such as a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, or an n-butoxy group.
[0099] Examples of the electron-withdrawing group include a carboxy group, a cyano group, an aldehyde group, an ester group, a nitro group, a halogen atom, a phenyl group, an acyl group, and a sulfone group. Of these, the electron-withdrawing group is preferably a nitro group.
[0100] (Production method of compound (a)) An example of a method for producing compound (a) will be described below. As an example of the method for producing compound (a), first, a compound represented by general formula (X) and a base represented by general formula (b) are prepared. R2 in general formula (X) is the same as R2 in general formula (a), and X represents a halogen atom (e.g., a chlorine atom).
[0101] Next, the compound represented by the general formula (X) and the base represented by the general formula (b) are mixed and reacted, whereby, as shown in the following reaction formula, the carbon atom of the carbonyl group in the compound represented by the general formula (X) is bonded to the nitrogen atom in the base represented by the general formula (b) to obtain the compound represented by the general formula (a).
[0102] [ka]
[0103] In the method for producing the compound represented by the general formula (a) described above, the compound represented by the general formula (a) can be produced simply by a one-step reaction. Note that the method for producing the compound represented by the general formula (a) of the present disclosure is not limited to the above-mentioned method, and may be produced by other methods. When the compound represented by the general formula (X) and the base represented by the general formula (b) are mixed, they may be dissolved in a solvent such as tetrahydrofuran and then mixed. The reaction temperature and reaction time of the compound represented by formula (X) and the base represented by formula (b) are not particularly limited. For example, the reaction temperature may be 0° C. to 50° C., and the reaction time may be 0.5 hours to 48 hours. The above reactions may employ a catalyst, such as an amine catalyst.
[0104] The content of the (D) curing agent is preferably 1% by mass to 40% by mass, more preferably 2% by mass to 35% by mass, and even more preferably 3% by mass to 10% by mass, based on the total solid content of the curable composition. When the content of the (D) curing agent is 1% by mass or more, the reaction of the (A) component proceeds more easily. In addition, when the content of the (D) curing agent is 40% by mass or less, excessive use of the (D) curing agent is suppressed.
[0105] ((E) Polymerizable compound) The curable composition of the present disclosure preferably contains a polymerizable compound (E) as a component other than the compound having an epoxy group (A) and the compound having a carboxy group (B). The polymerizable compound (E) is a compound having at least one ethylenically unsaturated group in the molecule, and preferably a compound having two or more ethylenically unsaturated groups in one molecule. The polymerizable compound (E) may be a photopolymerizable compound that can be polymerized by irradiation with light.
[0106] Examples of the polymerizable compound (E) include (meth)acrylate compounds, acrylonitrile, acrylamide compounds, vinyl compounds, styrene, esters of polyhydric or monohydric alcohols and unsaturated carboxylic acids, hydrocarbons having one ethylenically unsaturated bond, and derivatives thereof. Among these, it is preferable that the polymerizable compound (E) contains a (meth)acrylate compound. The (E) polymerizable compound may be used alone or in combination of two or more kinds.
[0107] The number of ethylenically unsaturated groups contained in the polymerizable compound (E) is not particularly limited, and may be, for example, 1 to 8, 2 to 6, or 3 or 4.
[0108] Examples of the (E) polymerizable compound having two or more ethylenically unsaturated groups in one molecule include, for example, esters of an aliphatic polyhydroxy compound and an unsaturated carboxylic acid; esters of an aromatic polyhydroxy compound and an unsaturated carboxylic acid; esters obtained by esterification reaction of a polyhydric hydroxy compound such as an aliphatic polyhydroxy compound or an aromatic polyhydroxy compound with an unsaturated carboxylic acid and a polybasic carboxylic acid. The above-mentioned esters may be single substances or mixtures containing unreacted components, by-products, and the like.
[0109] Examples of the esters of aliphatic polyhydroxy compounds and unsaturated carboxylic acids include acrylic acid esters of aliphatic polyhydroxy compounds such as ethylene glycol diacrylate, triethylene glycol diacrylate, trimethylolpropane triacrylate, trimethylolethane triacrylate, pentaerythritol diacrylate, pentaerythritol triacrylate, pentaerythritol tetraacrylate, dipentaerythritol tetraacrylate, dipentaerythritol pentaacrylate, dipentaerythritol hexaacrylate, and glycerol acrylate; methacrylic acid esters in which the acrylate of these exemplary compounds is replaced with methacrylate; itaconic acid esters in which itaconate is replaced with itaconate; crotonic acid esters in which cronate is replaced with crotonate; and maleic acid esters in which maleate is replaced with maleate.
[0110] Examples of the esters of aromatic polyhydroxy compounds and unsaturated carboxylic acids include acrylic acid esters and methacrylic acid esters of aromatic polyhydroxy compounds such as hydroquinone diacrylate, hydroquinone dimethacrylate, resorcinol diacrylate, resorcinol dimethacrylate, and pyrogallol triacrylate. Examples of esters obtained by an esterification reaction between a polybasic carboxylic acid and an unsaturated carboxylic acid and a polyvalent hydroxy compound include condensates of acrylic acid, phthalic acid, and ethylene glycol, condensates of acrylic acid, maleic acid, and diethylene glycol, condensates of methacrylic acid, terephthalic acid, and pentaerythritol, and condensates of acrylic acid, adipic acid, butanediol, and glycerin.
[0111] The content of the (E) polymerizable compound may be 10% by mass to 50% by mass, 15% by mass to 45% by mass, or 20% by mass to 40% by mass, based on the total solid content of the curable composition.
[0112] ((F) Photopolymerization initiator) The curable composition of the present disclosure preferably contains a photopolymerization initiator (F). The photopolymerization initiator (F) is a component that absorbs light, causes a decomposition reaction or a hydrogen abstraction reaction, and generates a polymerization active radical. If necessary, the photopolymerization initiator may be used in combination with an additive such as a polymerization accelerator (chain transfer agent) or a sensitizing dye.
[0113] Examples of the photopolymerization initiator include metallocene compounds including titanocene compounds described in JP-A-59-152396 and JP-A-61-151197, hexaarylbiimidazole derivatives described in JP-A-2000-56118, halomethylated oxadiazole derivatives and halomethyl-s-triazine derivatives described in JP-A-10-39503, α-aminoalkylphenone derivatives, and oxime ester compounds described in JP-A-2000-80068 and JP-A-2006-36750. Oxime ester compounds are preferred from the viewpoints of sensitivity, plate making properties, etc. As the photopolymerization initiator, for example, photopolymerization initiators described in Japanese Patent No. 4454067, International Publication No. 2002 / 100903, International Publication No. 2012 / 45736, International Publication No. 2015 / 36910, International Publication No. 2006 / 18973, International Publication No. 2008 / 78678, Japanese Patent No. 4818458, International Publication No. 2005 / 80338, International Publication No. 2008 / 75564, International Publication No. 2009 / 131189, International Publication No. 2010 / 133077, International Publication No. 2010 / 102502, and International Publication No. 2012 / 68879 may be used. The initiators described in JP 2016-133574 A are also suitably used. The (F) photopolymerization initiator may be used alone or in combination of two or more kinds.
[0114] Examples of the metallocene compound include dicyclopentadienyltitanium dichloride, dicyclopentadienyltitanium bisphenyl, dicyclopentadienyltitanium bis(2,3,4,5,6-pentafluorophenyl-1-yl), dicyclopentadienyltitanium bis(2,3,5,6-tetrafluorophenyl-1-yl), dicyclopentadienyltitanium bis(2,4,6-trifluorophenyl-1-yl), dicyclopentadienyltitanium Examples of the titanium bis(2,3,4,5,6-pentafluorophenyl-1-yl), di(methylcyclopentadienyl)titanium bis(2,6-difluorophenyl-1-yl), dicyclopentadienyltitanium [2,6-difluoro-3-(pyrro-1-yl)-phenyl-1-yl] are mentioned.
[0115] Examples of hexaarylbiimidazole derivatives include 2-(2'-chlorophenyl)-4,5-diphenylimidazole dimer, 2-(2'-chlorophenyl)-4,5-bis(3'-methoxyphenyl)imidazole dimer, 2-(2'-fluorophenyl)-4,5-diphenylimidazole dimer, 2-(2'-methoxyphenyl)-4,5-diphenylimidazole dimer, and (4'-methoxyphenyl)-4,5-diphenylimidazole dimer.
[0116] Examples of halomethylated oxadiazole derivatives include 2-trichloromethyl-5-(2'-benzofuryl)-1,3,4-oxadiazole, 2-trichloromethyl-5-[β-(2'-benzofuryl)vinyl]-1,3,4-oxadiazole, 2-trichloromethyl-5-[β-(2'-(6''-benzofuryl)vinyl)]-1,3,4-oxadiazole, and 2-trichloromethyl-5-furyl-1,3,4-oxadiazole.
[0117] Examples of halomethyl-s-triazine derivatives include 2-(4-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-methoxynaphthyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-ethoxynaphthyl)-4,6-bis(trichloromethyl)-s-triazine, and 2-(4-ethoxycarbonylnaphthyl)-4,6-bis(trichloromethyl)-s-triazine.
[0118] Examples of α-aminoalkylphenone derivatives include 2-methyl-1[4-(methylthio)phenyl]-2-morpholinopropan-1-one, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)butan-1-one, 2-dimethylamino-2-(4-methylbenzyl)-1-(4-morpholinophenyl)butan-1-one, and 3,6-bis(2-methyl-2-morpholinopropionyl)-9-octylcarbazole.
[0119] An example of the oxime ester compound is a compound represented by the following general formula (IV).
[0120] [ka]
[0121] In formula (IV), R 21a represents a hydrogen atom, an alkyl group which may have a substituent, or an aromatic ring group which may have a substituent. R 21b represents an optional substituent containing an aromatic ring. R 22a represents an alkanoyl group which may have a substituent, or an aroyl group which may have a substituent. n represents an integer of 0 or 1.
[0122] R 21a The number of carbon atoms in the alkyl group is not particularly limited. From the viewpoint of solubility in a solvent, sensitivity, etc., it is preferably 1 or more, more preferably 2 or more, and is preferably 20 or less, more preferably 15 or less, and even more preferably 10 or less. For example, the alkyl group includes a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a cyclopentyl methyl group, a cyclopentyl ethyl group, a cyclohexyl methyl group, and a cyclohexyl ethyl group. Examples of the substituent that the alkyl group may have include an aromatic ring group, a hydroxyl group, a carboxyl group, a halogen atom, an amino group, an amide group, a 4-(2-methoxy-1-methyl)ethoxy-2-methylphenyl group, or an N-acetyl-N-acetoxyamino group. From the viewpoint of ease of synthesis, it is preferable that the alkyl group is unsubstituted.
[0123] R 21a The aromatic ring group in the formula (I) includes an aromatic hydrocarbon ring group and an aromatic heterocyclic group. The number of carbon atoms in the aromatic ring group is not particularly limited. From the viewpoint of solubility in the curable composition, it is preferably 5 or more. From the viewpoint of developability, it is preferably 30 or less, more preferably 20 or less, and even more preferably 12 or less.
[0124] Examples of the aromatic ring group include a phenyl group, a naphthyl group, a pyridyl group, and a furyl group. From the viewpoint of developability, the phenyl group and the naphthyl group are preferred, and the phenyl group is more preferred. Examples of the substituent that the aromatic ring group may have include a hydroxyl group, a carboxyl group, a halogen atom, an amino group, an amide group, an alkyl group, an alkoxy group, and a group in which these substituents are linked. From the viewpoint of developability, an alkyl group, an alkoxy group, and a group in which these substituents are linked are preferred, and a linked alkoxy group is more preferred. From the viewpoint of developability, R 21a is preferably an aromatic ring group which may have a substituent, and more preferably an aromatic ring group having an alkoxy group linked thereto as a substituent.
[0125] R 21b Examples of the alkyl group include an optionally substituted carbazolyl group, an optionally substituted thioxanthonyl group, an optionally substituted diphenylsulfide group, an optionally substituted fluorenyl group, and an optionally substituted indolyl group. From the viewpoints of sensitivity and solvent resistance, an optionally substituted carbazolyl group is preferred.
[0126] R 22a The number of carbon atoms in the alkanoyl group in is not particularly limited, and from the viewpoints of solubility in a solvent, sensitivity, etc., it is preferably 2 or more, and is preferably 20 or less, more preferably 15 or less, even more preferably 10 or less, and particularly preferably 5 or less. For example, examples of the alkanoyl group include an acetyl group, a propanoyl group, and a butanoyl group. Examples of the substituent that the alkanoyl group may have include an aromatic ring group, a hydroxyl group, a carboxyl group, a halogen atom, an amino group, and an amide group. From the viewpoint of ease of synthesis, the alkanoyl group is preferably unsubstituted.
[0127] R 22aThe number of carbon atoms in the aroyl group is not particularly limited. From the viewpoints of solubility in a solvent, sensitivity, etc., it is preferably 7 or more, and is preferably 20 or less, more preferably 15 or less, and even more preferably 10 or less. Examples of the aroyl group include a benzoyl group and a naphthoyl group. Examples of the substituent that the aroyl group may have include a hydroxyl group, a carboxy group, a halogen atom, an amino group, an amide group, and an alkyl group. From the viewpoint of ease of synthesis, it is preferable that the aroyl group is unsubstituted. From the perspective of sensitivity, R 22a is preferably an alkanoyl group which may have a substituent, more preferably an unsubstituted alkanoyl group, and further preferably an acetyl group. Among these photopolymerization initiators, the oxime ester compounds are more preferable.
[0128] In the curable composition, a sensitizing dye and a polymerization accelerator according to the wavelength of the exposure light source may be used as necessary for the purpose of increasing sensitivity.
[0129] (Sensitizing dye) Examples of sensitizing dyes include xanthene dyes described in JP-A-4-221958 and JP-A-4-219756, coumarin dyes having a heterocycle described in JP-A-3-239703 and JP-A-5-289335, 3-ketocoumarin compounds described in JP-A-3-239703 and JP-A-5-289335, pyrromethene dyes described in JP-A-6-19240, JP-A-47-2528 and JP-A-54-155292. and dyes having a dialkylaminobenzene skeleton, as described in JP-B-37377, JP-A-48-84183, JP-A-52-112681, JP-A-58-15503, JP-A-60-88005, JP-A-59-56403, JP-A-2-69, JP-A-57-168088, JP-A-5-107761, JP-A-5-210240, and JP-A-4-288818.
[0130] The sensitizing dye is preferably an amino group-containing sensitizing dye, and more preferably a compound having an amino group and a phenyl group in the same molecule. For example, benzophenone compounds such as 4,4'-dimethylaminobenzophenone, 4,4'-diethylaminobenzophenone, 2-aminobenzophenone, 4-aminobenzophenone, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, and 3,4-diaminobenzophenone; 2-(p-dimethylaminophenyl)benzoxazole, 2-(p-diethylaminophenyl)benzoxazole, 2-(p-dimethylaminophenyl)benzo[4,5]benzoxazole, 2-(p-dimethylaminophenyl)benzo[6,7]benzoxazole, 2,5-bis(p-diethylaminophenyl)-1,3,4-oxazole, 2-(p-dimethylaminophenyl)benzo[4,5]benzoxazole, 2-(p-dimethylaminophenyl)benzo[6,7]benzoxazole, 2,5-bis(p-diethylaminophenyl)-1,3,4-oxazole, and 2-(p-dimethylaminophenyl)benzo[4,5]benzoxazole. p-Dialkylaminophenyl group-containing compounds such as (p-phenyl)benzothiazole, 2-(p-diethylaminophenyl)benzothiazole, 2-(p-dimethylaminophenyl)benzimidazole, 2-(p-diethylaminophenyl)benzimidazole, 2,5-bis(p-diethylaminophenyl)-1,3,4-thiadiazole, (p-dimethylaminophenyl)pyridine, (p-diethylaminophenyl)pyridine, (p-dimethylaminophenyl)quinoline, (p-diethylaminophenyl)quinoline, (p-dimethylaminophenyl)pyrimidine, and (p-diethylaminophenyl)pyrimidine are preferred, and 4,4'-dialkylaminobenzophenone is particularly preferred. The sensitizing dyes may be used alone or in combination of two or more kinds.
[0131] (Polymerization accelerator) Examples of the polymerization accelerator include aromatic amines such as ethyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, 4-dimethylaminoacetophenone, and 4-dimethylaminopropiophenone; aliphatic amines such as n-butylamine, N-methyldiethanolamine, and 2-dimethylaminoethyl benzoate; and mercapto compounds. The polymerization accelerator may be used alone or in combination of two or more kinds.
[0132] The curable composition of the present disclosure preferably contains a colorant (G). By containing a colorant (G), appropriate light absorption properties can be obtained, particularly appropriate light shielding properties when the curable composition is used for forming a light shielding member such as a partition wall.
[0133] The type of colorant (G) is not particularly limited, and examples include pigments, dyes, etc. From the viewpoint of durability, pigments are preferred. The (G) colorant may be used alone or in combination of two or more kinds. For example, two colorants of different colors may be used in combination.
[0134] The type of pigment is not particularly limited, and examples thereof include organic color pigments and black pigments. Organic color pigments refer to organic pigments that exhibit a color other than black, and examples thereof include red pigments, orange pigments, blue pigments, purple pigments, green pigments, and yellow pigments. From the viewpoint of the light-shielding properties and shape control of the cured product, it is preferable to use at least one pigment selected from the group consisting of red pigments, orange pigments, blue pigments, and purple pigments.
[0135] As the pigment, an organic pigment is preferred from the viewpoint of high dielectric constant and low dielectric constant. An organic coloring pigment is preferred from the viewpoint of suppressing absorption of ultraviolet light, high curability, and easy control of the shape of the cured product. A black pigment is preferred from the viewpoint of light blocking properties.
[0136] The chemical structure of the organic color pigment is not particularly limited, and examples thereof include azo-based, phthalocyanine-based, quinacridone-based, benzimidazolone-based, isoindolinone-based, dioxazine-based, indanthrene-based, and perylene-based.
[0137] When two or more organic color pigments are used in combination, the combination of the organic color pigments is not particularly limited. From the viewpoint of light-shielding properties, the (G) colorant preferably contains at least one selected from the group consisting of red pigments and orange pigments, and at least one selected from the group consisting of blue pigments and purple pigments. The color combination is not particularly limited. From the viewpoint of light blocking properties, for example, a combination of a red pigment and a blue pigment, a combination of a blue pigment and an orange pigment, or a combination of a blue pigment, an orange pigment and a purple pigment may be used.
[0138] Examples of black pigments include organic black pigments and inorganic black pigments. From the viewpoint of light-shielding properties and insulation properties, organic black pigments are preferred. From the viewpoint of high light-shielding properties, inorganic black pigments are preferred.
[0139] Examples of inorganic black pigments include carbon black, acetylene black, lamp black, bone black, graphite, iron black, cyanine black, and titanium black. From the viewpoint of light-shielding properties and image characteristics, carbon black is preferred.
[0140] Examples of carbon black include the following: Mitsubishi Chemical: MA7, MA8, MA11, MA77, MA100, MA100R, MA100S, MA220, MA230, MA600, MCF88, #5, #10, #20, #25, #30, #32, #33, #40, #44, #45, #47, #50, #52, #55, #650, #750, #850, #900, #950, # 960, #970, #980, #990, #1000, #2200, #2300, #2350, #2400, #2600, #2650, #3030, #3050, #31 50, #3250, #3400, #3600, #3750, #3950, #4000, #4010, OIL7B, OIL9B, OIL11B, OIL30B, OIL31B Manufactured by Degussa: Printex (registered trademark, same hereinafter) 3, Printex3OP, Printex30, Printex30OP, Printex40, Printex45, Printex55, Printex60, Printex75, Printex80, Printex85, Printex90, Printex A, Printex L, Printex G, Printex P, Printex U, Printex V, PrintexG, SpecialBlack550, SpecialBlack350, SpecialBlack250, SpecialBlack100, SpecialBlack6, SpecialBlack5, SpecialBlack4, Color Black FW1, Color Black FW2, Color Black FW2V, Color Black FW18, Color Black FW200, Color Black S160, Color Black S170 Cabot Corporation: Monarch (registered trademark, the same applies below) 120, Monarch 280, Monarch 460, Monarch 800, Monarch 880, Monarch 900, Monarch 1000, Monarch 1100, Monarch 1300, Monarch 1400, Monarch 4630, REGAL (registered trademark, the same applies below) 99, REGAL 99R, REGAL 415, REGAL 415R, REGAL 250, REGAL 250R, REGAL 330, REGAL 400R, REGAL 550R, REGAL 660R, BLACK PEARLS 480, PEARLS 130, VULCAN (registered trademark, the same applies below) XC72R, ELFTEX (registered trademark)-8 Biller: RAVEN (registered trademark, the same applies below) 11, RAVEN14, RAVEN15, RAVEN16, RAVEN22, RAVEN30, RAVEN35, RAVEN40, RAVEN410, RAVEN420, RAVEN450, RAVEN500, RAVEN780, RAVEN850, RAVEN890H, RAVEN1000, RAVEN1020, RAVEN1040, RAVEN1060U, RAVEN1080U, RAVEN1170, RAVEN1190U, RAVEN1250, RAVEN1500, RAVEN2000, RAVEN2500U, RAVEN3500, RAVEN5000, RAVEN5250, RAVEN5750, RAVEN7000
[0141] As the carbon black, acidic carbon black as described in Japanese Patent No. 3644201 may be used.
[0142] Carbon black may be coated with a resin. Carbon black coated with a resin has the effect of improving adhesion to a glass substrate, volume resistivity, etc. Examples of carbon black coated with a resin include carbon black described in Japanese Patent Application Laid-Open No. 09-71733. From the viewpoint of volume resistivity, dielectric constant, etc., resin-coated carbon black is preferably used.
[0143] Examples of organic black pigments include perylene black, aniline black, lactam black, etc. From the viewpoints of light-shielding properties and dispersibility, lactam black is preferred.
[0144] The content of the (G) colorant may be 5% by mass to 50% by mass, 5% by mass to 40% by mass, 10% by mass to 30% by mass, or 15% by mass to 25% by mass, relative to the total solid content of the curable composition.
[0145] The (G) colorant may be used in combination with a dispersant, a dispersion aid, etc. This makes it possible to finely disperse the (G) colorant in the curable composition and stabilize the dispersed state.
[0146] (Dispersant) The curable composition may contain a dispersant. In particular, when the curable composition contains a colorant (G), it is preferable that the curable composition contains a dispersant.
[0147] The dispersant is preferably a polymer dispersant having a functional group, and furthermore, from the viewpoint of dispersion stability, a polymer dispersant having a functional group such as a carboxy group, a phosphoric acid group, a sulfonic acid group, or a base thereof, a primary, secondary or tertiary amino group, a quaternary ammonium base, or a group derived from a nitrogen-containing heterocycle such as pyridine, pyrimidine or pyrazine is preferred. In particular, a polymer dispersant having a basic functional group such as a primary, secondary or tertiary amino group, a quaternary ammonium base, or a group derived from a nitrogen-containing heterocycle such as pyridine, pyrimidine or pyrazine is preferred from the viewpoint of being able to disperse the pigment with a small amount of dispersant. The dispersant may be used alone or in combination of two or more kinds.
[0148] Examples of polymeric dispersants include urethane-based dispersants, acrylic-based dispersants, polyethyleneimine-based dispersants, polyallylamine-based dispersants, dispersants consisting of a monomer and a macromonomer having an amino group, polyoxyethylene alkyl ether-based dispersants, polyoxyethylene diester-based dispersants, polyether phosphate-based dispersants, polyester phosphate-based dispersants, sorbitan aliphatic ester-based dispersants, and aliphatic modified polyester-based dispersants.
[0149] Examples of commercially available dispersants include, by trade name, EFKA (registered trademark, manufactured by BASF), DISPERBYK (registered trademark, manufactured by BYK-Chemie), Disparlon (registered trademark, manufactured by Kusumoto Chemical Industries, Ltd.), SOLSPERSE (registered trademark, manufactured by Lubrizol Corporation), KP (manufactured by Shin-Etsu Chemical Co., Ltd.), Polyflow (manufactured by Kyoeisha Chemical Co., Ltd.), and AJISPER (registered trademark, manufactured by Ajinomoto Co., Ltd.).
[0150] The weight average molecular weight (Mw) of the polymer dispersant is preferably 700 or more, more preferably 1000 or more, and is preferably 100,000 or less, more preferably 50,000 or less. The above upper and lower limits can be arbitrarily combined. For example, the weight average molecular weight (Mw) of the polymer dispersant is preferably 700 to 100,000, more preferably 1,000 to 50,000. Examples of urethane-based and acrylic-based dispersants include DISPERBYK-160 to 167, 182 series (all urethane-based), DISPERBYK-2000, 2001, BYK-LPN6919, BYK-LPN21116 (all acrylic-based) (all manufactured by BYK-Chemie). From the viewpoints of dispersibility and storage stability, polymer dispersants having a basic functional group and either or both of a polyester bond and a polyether bond are preferred.
[0151] The content of the dispersant relative to the colorant (G) may be 5% by mass to 40% by mass, 10% by mass to 30% by mass, or 15% by mass to 25% by mass.
[0152] (Dispersion aid) The curable composition may contain a dispersing aid. In particular, when the curable composition contains a colorant (G), it is preferable to contain a dispersing aid together with the dispersant from the viewpoint of improving dispersibility and storage stability.
[0153] The dispersing aid may be a pigment derivative. Examples of pigment derivatives include azo-based, phthalocyanine-based, quinacridone-based, benzimidazolone-based, quinophthalone-based, isoindolinone-based, dioxazine-based, anthraquinone-based, indanthrene-based, perylene-based, perinone-based, diketopyrrolopyrrole-based, and dioxazine-based derivatives, with phthalocyanine-based and quinophthalone-based derivatives being preferred. Examples of the substituent of the pigment derivative include a sulfonic acid group, a sulfonamide group and its quaternary salt, a phthalimidomethyl group, a dialkylaminoalkyl group, a hydroxyl group, a carboxyl group, an amide group, etc., which are bonded to the pigment skeleton directly or via an alkyl group, an aryl group, a heterocyclic group, etc., and preferably a sulfonic acid group. One pigment skeleton may have multiple substituents. The dispersion aid may be used alone or in combination of two or more kinds.
[0154] . Examples of the pigment derivatives include sulfonic acid derivatives of phthalocyanine, sulfonic acid derivatives of quinophthalone, sulfonic acid derivatives of anthraquinone, sulfonic acid derivatives of quinacridone, sulfonic acid derivatives of diketopyrrolopyrrole, and sulfonic acid derivatives of dioxazine.
[0155] The content of the dispersing aid relative to the colorant (G) may be 1% by mass to 10% by mass, 1.5% by mass to 8% by mass, or 2% by mass to 5% by mass.
[0156] The curable composition may contain other components in addition to the above-mentioned components, such as an adhesion improver such as a silane coupling agent, a surfactant, a photoacid generator, a crosslinking agent, a mercapto compound, a polymerization inhibitor, a filler, and other additives. The other components may be used alone or in combination of two or more.
[0157] (solvent) The curable composition may contain a solvent from the viewpoints of the coatability, handling properties, and the like of the curable composition.
[0158] Examples of the solvent include glycol monoalkyl ethers; glycol dialkyl ethers; glycol alkyl ether acetates; glycol diacetates; alkyl acetates; ethers; ketones; monohydric or polyhydric alcohols; alicyclic hydrocarbons; aromatic hydrocarbons; chain or cyclic esters; halogenated hydrocarbons; ether ketones; and the like. The solvent may be used alone or in combination of two or more kinds.
[0159] The solvent is preferably glycol alkyl ether acetates, which have a good balance of application properties, surface tension, etc., and have relatively high solubility of the components in the composition. Preferred examples of glycol alkyl ether acetates include ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol mono-n-butyl ether acetate, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, propylene glycol monobutyl ether acetate, methoxybutyl acetate, 3-methoxybutyl acetate, methoxypentyl acetate, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol mono-n-butyl ether acetate, dipropylene glycol monomethyl ether acetate, triethylene glycol monomethyl ether acetate, triethylene glycol monoethyl ether acetate, and 3-methyl-3-methoxybutyl acetate.
[0160] [Cured product] The cured product of the present disclosure is obtained by curing the curable composition of the present disclosure. A method for producing the cured product of the present disclosure will be described later in the method for producing the cured product of the present disclosure. The shape of the cured product of the present disclosure can be selected arbitrarily depending on the purpose, for example, in the form of a film, a line, or the like.
[0161] The uses of the cured product of the present disclosure are not particularly limited, and examples thereof include color filters, partition walls, and image display devices.
[0162] The color filter may include the cured product of the present disclosure. For example, the color filter may include a cured product and an alignment film formed from a liquid crystal aligning agent and laminated on the cured product.
[0163] The partition wall may include the cured product of the present disclosure. For example, the partition wall may be a partition wall for partitioning pixel portions in a color filter.
[0164] An image display device may include the cured product of the present disclosure. For example, the image display device may include a color filter and a partition wall for partitioning pixel portions of the color filter, and at least one of the color filter and the pixel portions may contain the cured product.
[0165] The cured product of the present disclosure can be produced by forming a coating film of the curable composition on a substrate and heating the coating film.
[0166] Examples of methods for forming a coating film include a method in which the curable composition is applied to a substrate using a coating means such as a spin coater (spinner), air knife coater, blade coater, bar coater, gravure coater, roll coater, roll knife coater, curtain coater, die coater, knife coater, screen coater, Mayer bar coater, or kiss coater, or an applicator, or a method in which the curable composition is adhered to a substrate by immersing the substrate in the curable composition. For example, when producing a film-like or linear cured product, a coating film of the curable composition may be formed on a substrate by using a printing method such as screen printing, flexographic printing, offset printing, inkjet printing, dispenser printing, jet dispenser printing, gravure printing, gravure offset printing, or pad printing.
[0167] The heating temperature of the coating film may be 180°C or lower, may be 50°C to 180°C, or may be 70°C to 140°C. The heating time for the coating film may be from 10 minutes to 3 hours, or from 20 minutes to 2 hours.
[0168] [Method of manufacturing the cured product] When the curable composition of the present disclosure contains a (F) photopolymerization initiator, that is, when a photosensitive curable composition is used, the method for producing a cured product of the present disclosure can produce a cured product through at least the following steps (1) to (4). Step (1): Forming a coating film of the curable composition on a substrate Step (2): A step of exposing at least a part of the coating film formed in step (1) to light. Step (3): A step of developing the coating film exposed in step (2) Step (4): Heating the coating film developed in step (3)
[0169] In step (1), a coating film of the curable composition is formed on a substrate. The coating film can be formed by the above-mentioned methods.
[0170] In the manufacturing method of the present disclosure, at least a portion of the coating film is exposed to light in steps (2) and (3), and the exposed coating film is developed to obtain a coating film having a specific shape, specific pattern, etc.
[0171] In step (2), for example, a negative mask is used to irradiate the coating film with active energy rays such as ultraviolet light and excimer laser light, thereby partially exposing the coating film. For exposure, a light source that emits ultraviolet light such as a high-pressure mercury lamp, an ultra-high-pressure mercury lamp, a xenon lamp, or a carbon arc lamp can be used. The exposure dose can be appropriately adjusted depending on the composition of the curable composition, and is, for example, 100 mJ / cm. 2 ~400mJ / cm 2 is preferred.
[0172] In step (4), the coating film developed in step (3) is heated. This generates a base having a 4-aminopyridine skeleton that is highly reactive to epoxy groups from the thermal base generator contained in the curing agent (D). The action of the generated base causes a crosslinking reaction based on the epoxy ring-opening of component (A) to proceed, producing a cured product.
[0173] In step (4), the heating temperature of the developed coating film may be 180°C or less, may be 50°C to 180°C, may be 70°C to 140°C, may be 70°C to 120°C, or may be 70°C to 100°C. The heating time for the coating film may be from 10 minutes to 3 hours, or from 20 minutes to 2 hours. In the present disclosure, a base having a 4-aminopyridine skeleton that is highly active against epoxy groups is generated by using a specific curing agent (D). Therefore, although the epoxy curing reaction is generally carried out at a high temperature of about 200° C., the epoxy curing reaction can be carried out at a lower temperature. EXAMPLES
[0174] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. The components of the curable compositions used in the following Examples and Comparative Examples are as follows: In preparing the curable compositions, carbon black ink and other components prepared as follows were used.
[0175] <Preparation of Carbon Black Ink> A carbon black ink was prepared by mixing a colorant, a dispersant, a dispersion aid (pigment derivative), and a solvent in the following composition and by the following method. Specifically, the solid contents of the colorant, dispersant, and dispersion aid, and the solvent were mixed in the following amounts: (Components and amounts used in preparing carbon black ink) Colorant: RAVEN 1060U (Biller, carbon black); 28.23 parts by weight Dispersant: DISPERBYK-167 (manufactured by BYK-Chemie, basic urethane dispersant); 5.93 parts by weight (solid content equivalent) Dispersing agent (pigment derivative): S12000 (manufactured by Lubrizol Corporation, a phthalocyanine pigment derivative having an acidic group); 0.85 parts by weight Solvent: propylene glycol monomethyl ether acetate (PGMEA); 64.99 parts by weight
[0176] These ingredients were thoroughly stirred and mixed to obtain a dispersion. Next, dispersion treatment was carried out for 6 hours in the range of 25°C to 45°C using a paint shaker. Zirconia beads with a diameter of 0.5 mm were used as the beads, and 180 parts by mass of the beads were added to 60 parts by mass of the dispersion liquid. After dispersion was completed, the beads and the dispersion liquid were separated using a filter to obtain a carbon black ink with a solid content of 30% by mass.
[0177] <Preparing other ingredients> Other components used in preparing the curable composition are as follows: (Hardening agent-I) 4-Methoxy-N-methyl-N-4-pyridinylbenzamide (in the general formula (a-1), R1 is a methyl group, R 11 ~R 14 and R 21 ~R 24 is a hydrogen atom and R is a methoxy group, hereinafter also referred to as "compound (a)-1.") -Synthesis of compound (a)-1- The compound (a)-1 was synthesized by reacting 4-methoxybenzoyl chloride (compound (X-1)) with 4-(methylamino)pyridine as shown below. Compound (X-1) (3.0 g, 17 mmol) and dry tetrahydrofuran (20 mL) were added to a two-neck flask. A mixture of 4-(methylamino)pyridine (1.8 g, 17 mmol), triethylenediamine (TEA, 3.0 g, 30 mmol) and dry tetrahydrofuran (30 mL) was added dropwise to the solution of compound (X-1) in an ice bath using a dropping funnel. The mixture was then stirred at room temperature for 24 hours to carry out the reaction. The resulting reaction solution was purified by silica gel column chromatography using ethyl acetate as the mobile phase to obtain the target compound (a)-1 as a white solid (yield: 2.1 g, 53%).
[0178] [ka]
[0179] The obtained compound (a)-1 1 H-NMR and 13 The results of the C-NMR analysis are shown in Table 1. In addition, the compound (a)-1 obtained was subjected to simultaneous differential thermal and thermogravimetric (TG-DTA) measurements at a heating rate of 5°C / min and a measurement temperature range of 20°C to 300°C. d5 ) was 239°C.
[0180] [Table 1]
[0181] (Basic Compound-I) 4-Methylaminopyridine (Tokyo Chemical Industry Co., Ltd.)
[0182] (Compound-I) An alkali-soluble epoxy compound having dicyclopentanyl methacrylate / glycidyl methacrylate / methacrylic acid / 2-ethylhexyl acrylate (molar ratio: 0.15 / 0.45 / 0.25 / 0.15) as constituent monomers was designated as Compound-I. Compound I has a polystyrene-equivalent weight average molecular weight (Mw) of 8600 and a solid acid value of 84.4 mgKOH / g as measured by GPC. Compound-I is a compound containing an epoxy group and a carboxy group, and serves as both (A) a compound having an epoxy group and (B) a compound having a carboxy group.
[0183] (Photopolymerizable compound-I) Trimethylolpropane triacrylate (Kyoeisha Chemical Co., Ltd., Light Acrylate TMP)
[0184] (Photopolymerization initiator-I) ADEKA Arcles NCI-831E
[0185] (Surfactant-I) DIC Megafack F-559
[0186] (Adhesion improver-I) KAYAMER PM-21 manufactured by Nippon Kayaku Co., Ltd.
[0187] (solvent) Solvent-I: PGMEA (propylene glycol monomethyl ether acetate)
[0188] <Preparation of Curable Composition> Each component was added so that the ratio of the solid content of each component in the total solid content was the blending ratio in Table 2, and solvent-I was added so that the content ratio of the total solid content was 17 mass%, and the mixture was stirred to prepare the curable composition of each Example and each Comparative Example. The curable composition of each Example and each Comparative Example is a photosensitive curable composition because it contains photopolymerization initiator-I and photopolymerizable compound-I. Using each obtained curable composition, evaluations were performed on the items listed in Table 2 by the method described below. The blending ratios of colorant, dispersant, dispersion aid, curing agent, basic compound, photopolymerizable compound, Compound-I, photopolymerization initiator, surfactant, and adhesion promoter in Table 2 are calculated based on solid content. A blank in Table 2 means that the corresponding component is not blended.
[0189] <Preparation of substrate for evaluating solvent resistance> The curable composition was applied onto a glass substrate using a spinner so that the thickness would be 1 μm after heat curing. The obtained substrate was vacuum dried for 1 minute, and then heated and dried on a hot plate at 60° C. for 180 seconds to obtain a coated substrate. Next, a manual exposure machine (MA-1100) manufactured by Dainihon Kaken Co., Ltd. was used, and a high-pressure mercury lamp was used with a cut filter for wavelengths of 330 nm or less to expose the substrate to a light of 100 mJ / cm. 2 The entire surface of the coated substrate was exposed to light with a light intensity of 85 mW / cm at a wavelength of 365 nm. 2 Finally, the entire surface exposed substrate was heat cured in an oven at 85° C. for 60 minutes to obtain a substrate for evaluating solvent resistance.
[0190] <Solvent resistance evaluation> Solvent resistance evaluation was performed by immersing the substrate in PGMEA. The thickness of the substrate was measured using a Hitachi High-Tech Science white light interferometer VertScan, and then the substrate was immersed in PGMEA at 23.0±1.0°C for 1 hour. After the substrate was immersed in PGMEA, it was air-dried for 24 hours, and the thickness was measured again and the remaining film ratio was calculated using the following formula. Remaining film rate (%) = [(film thickness after immersion in PGMEA [μm]) / (film thickness before immersion in PGMEA [μm])] × 100 The results are shown in Table 2. If the remaining film rate was 90% or more, it was rated as "A (good)", and if it was less than 90%, it was rated as "B (poor)". The higher the remaining film rate, the better the solvent resistance.
[0191] <Optical density (OD) per unit film thickness> The optical density (OD) of the substrate for evaluating solvent resistance before immersion in PGMEA was measured using an X-Rite 361T(V) manufactured by Sakata Engineering Co., Ltd. The optical density value was divided by the film thickness value before immersion in PGMEA to calculate the optical density per unit film thickness (OD / μm). The results are shown in Table 2.
[0192] <Evaluation of viscosity stability over time> The prepared curable compositions were stored in a refrigerator at 5° C., and the viscosity was evaluated after one day and one week. The viscosity was measured at 23.0±1.0° C. using a Toki Sangyo Co., Ltd. E-type viscometer RE-85L. If the absolute value of the viscosity change after one day and after one hour was less than 1 mPa s, and the viscosity after one day and after one week was less than 10 mPa s, the product was rated as "A (good)". If the absolute value of the viscosity change from one day to one week was 1 mPa s or more, if the viscosity after one day or one week was 10 mPa s or more, or if solidification of the curable composition was confirmed within one week, the test was rated as "B (poor)". The results are shown in Table 2. The smaller the change in viscosity, the more excellent the stability over time.
[0193] [Table 2]
[0194] As shown in Table 2, both Examples 1 and 2 were good in both solvent resistance and viscosity stability over time. Comparative Examples 1 and 2 showed good stability over time, but poor solvent resistance. Comparative Examples 3 and 4 showed good solvent resistance, but poor viscosity stability over time.
[0195] Although the detailed mechanism of thermal curing at a low temperature of 85°C has not been clarified, it is considered as follows. It is presumed that, under a low temperature curing condition of 85°C, a nucleophilic acyl substitution reaction of the curing agent-I proceeds by the carboxylate derived from compound-I, which generates 4-methylaminopyridine that is highly active against epoxy groups, and a crosslinking reaction based on epoxy ring opening proceeds. In Examples 1 and 2, it is presumed that the crosslinking reaction proceeds with good reactivity due to the generation of 4-methylaminopyridine that is highly active against epoxy groups, and that good solvent resistance was exhibited. Furthermore, it is presumed that, under a low temperature storage condition of 5°C, the curing agent-I has low activity against epoxy groups, and therefore, in Examples 1 and 2, the viscosity stability over time was good.
[0196] On the other hand, in Comparative Examples 1 and 2, since there was no reactive group highly active against epoxy groups under the low-temperature curing condition of 85°C, it is presumed that the crosslinking reaction based on epoxy ring-opening did not proceed much, resulting in low solvent resistance. In Comparative Examples 3 and 4, it is presumed that the crosslinking reaction proceeded reactivity well due to the presence of basic compound-I under the low-temperature curing condition of 85°C, and good solvent resistance was exhibited. On the other hand, it is presumed that the crosslinking reaction proceeded over time due to the presence of basic compound-I under the low-temperature storage condition of 5°C, and the stability of viscosity over time was low.
Claims
1. (A) a compound having an epoxy group; (B) a compound having a carboxy group; and (D) a curing agent, The curable composition, wherein the (D) curing agent is a thermal base generator containing a compound represented by the following general formula (a) which generates a base having a 4-aminopyridine skeleton upon heating: [Formula 1] In general formula (a), R 1 is a hydrogen atom or a monovalent substituent, R 11 ~R 14 are each independently a hydrogen atom or a monovalent substituent, R 2 is a monovalent substituent in which the atom bonded to the carbonyl carbon in general formula (a) is a carbon atom, an oxygen atom, or a sulfur atom.
2. The curable composition according to claim 1 , further comprising (E) a polymerizable compound.
3. The curable composition according to claim 1 , further comprising (F) a photopolymerization initiator.
4. The curable composition of claim 1 , further comprising (G) a colorant.
5. The curable composition according to claim 2 , wherein the polymerizable compound (E) comprises a (meth)acrylate compound.
6. In general formula (a), R 1 The curable composition according to claim 1 , wherein: is a monovalent substituent, said monovalent substituent being an alkyl group.
7. In general formula (a), R 2 The curable composition according to claim 1, wherein: is an optionally substituted phenyl group, an optionally substituted alkoxy group, an optionally substituted alkyl group, or an optionally substituted thioalkyl group.
8. The curable composition according to claim 1, wherein the general formula (a) satisfies the following general formula (a-1): [Case 2] In general formula (a-1), R 1 is a hydrogen atom or a monovalent substituent, R 11 ~R 14 and R 21 ~R 24 are each independently a hydrogen atom or a monovalent substituent, R 3 is an electron donating group or an electron withdrawing group.
9. In general formula (a-1), R 3 The curable composition according to claim 8 , wherein is an alkoxy group or a nitro group.
10. A cured product obtained by curing the curable composition according to any one of claims 1 to 9.
11. A color filter comprising the cured product according to claim 10.
12. A partition wall comprising the cured product according to claim 10.
13. An image display device comprising the cured product according to claim 10.
14. A method for producing a cured product, comprising using the curable composition according to claim 3 and at least the following steps (1) to (4): Step (1): Forming a coating film of the curable composition on a substrate Step (2): A step of exposing at least a part of the coating film formed in step (1) to light. Step (3): A step of developing the coating film exposed in step (2) Step (4): Heating the coating film developed in step (3)
15. The method for producing a cured product according to claim 14, wherein the heating temperature in the step (4) is 180°C or lower.
Citation Information
Patent Citations
Radiation-sensitive resin composition, cured film, method for forming the same and color filter
JP2012048201A
